Revance Therapeutics Inc. buy Maxi_Scalibusa
Start price
17.02.19
/
50%
€15.82
Target price
03.04.19
€27.06
Performance (%)
-14.60%
End price
03.04.19
€13.51
Summary
This prediction ended on 03.04.19 with a price of €13.51. The prediction for Revance Therapeutics Inc. disappointed with a performance of -14.60%. Maxi_Scalibusa has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Revance Therapeutics Inc. | - | - | - | - |
iShares Core DAX® | 1.665% | 0.362% | 17.556% | 15.301% |
iShares Nasdaq 100 | -0.475% | -3.195% | 26.812% | 36.536% |
iShares Nikkei 225® | 2.620% | 1.174% | 17.273% | 10.880% |
iShares S&P 500 | -0.091% | -1.597% | 24.739% | 36.919% |
Comments by Maxi_Scalibusa for this prediction
In the thread Revance Therapeutics Inc. diskutieren
Revance Therapeutics
(Stop Loss Kurs erreicht)